Patents by Inventor Andres Lopez

Andres Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11168150
    Abstract: Described herein are antibodies, fragments thereof and multi-specific binding agents that bind an Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) peptide presented by HLA class I molecules, in particular, HLA-A02. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by expression of an EBV-LMP2 peptide presented by HLA-A02, in particular, Burkit's lymphoma, Hodgkin's lymphoma and nasopharyngeal carcinoma.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: November 9, 2021
    Assignees: Memorial Sloan Kettering Cancer Center, Eureka Therapeutics, Inc.
    Inventors: Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Cheng Liu, Su Yan, Jingyi Xiang, Hong Liu
  • Publication number: 20210324079
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 21, 2021
    Inventors: Nai-Kong V. Cheung, Andres Lopez-Albaitero, Hong Xu
  • Patent number: 11046768
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: June 29, 2021
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Nai-Kong V. Cheung, Andres Lopez-Albaitero, Hong Xu
  • Patent number: 11025439
    Abstract: A plurality of authentication devices form and manage a self-organizing mobile peer-to-peer mesh network to provide robust authentication of mobile peers, humans and or mobile devices such as drones, cars, satellites, robots etc. The mesh network may supplement traditional fixed point of entry authentication to combat social engineering penetrations or be used in situations where fixed-point authentication is not viable. Network efficiency can be enhanced by using two-level encryption, a first level of encryption based on permissions to join a mesh network and a simpler second level of encryption based on knowledge shared with members of the network for communication. Making the permissions a function of location can make the network more robust. Re-authenticating member peers based on the occurrence of defined events can further enhance security.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: June 1, 2021
    Assignee: Raytheon Company
    Inventors: David James Theodore, Blake Cameron Sims, Andres Rios, Hyperia Doe, Jesse Jonathan Lee, Alfonso Andres Lopez
  • Publication number: 20210153516
    Abstract: The present disclosure provides compositions and methods to promote improved delivery of volatile compounds to produce. As a result, the present disclosure provides more efficient and uniform delivery of volatile compounds and more effective control of spoilage organisms located on or near the stored produce.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 27, 2021
    Inventors: Daniel MACLEAN, Lei LIU, Alistair MCKAY, Elena RONDELLI, Andres LOPEZ
  • Publication number: 20200325435
    Abstract: The present disclosure relates to an apparatus and methods for measuring, monitoring, and/or controlling the chemical concentration of one or more active ingredients in a solution for treating plants and plant crops, such as fruits and vegetables.
    Type: Application
    Filed: April 14, 2020
    Publication date: October 15, 2020
    Inventors: Andrés LÓPEZ GÓMEZ, José M. PÉREZ CHECA
  • Publication number: 20200199248
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 25, 2020
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Nai-Kong V. CHEUNG, Andres LOPEZ-ALBAITERO, Hong XU
  • Patent number: 10626310
    Abstract: Fast light curing adhesive compositions, which include cyanoacrylate or methylidene malonate monomers or mixtures thereof, and either a photoinitiator system with a combination of specific ferrocene compounds and specific acylgermane compounds or a photoinitiator system with a specific ferrocene compound substituted with acylgermane groups. The use of that light curable adhesive composition, and a package.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: April 21, 2020
    Assignee: AFINITICA TECHNOLOGIES, S.L.
    Inventors: Juan Andrés López Maeso, Ciaran McArdle, Cristina Monfort Fraga, Verónica De La Fuente Molina, Arnau Pejoan Jiménez, Vladimir Tchaplinski
  • Publication number: 20200115470
    Abstract: Described herein are antibodies, fragments thereof and multi-specific binding agents that bind an Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) peptide presented by HLA class I molecules, in particular, HLA-A02. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by expression of an EBV-LMP2 peptide presented by HLA-A02, in particular, Burkit's lymphoma, Hodgkin's lymphoma and nasopharyngeal carcinoma.
    Type: Application
    Filed: October 28, 2019
    Publication date: April 16, 2020
    Inventors: Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Cheng Liu, Su Yan, Jingyi Xiang, Hong Liu
  • Patent number: 10519248
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: December 31, 2019
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Nai-Kong V. Cheung, Andres Lopez-Albaitero, Hong Xu
  • Patent number: 10501559
    Abstract: Described herein are antibodies, fragments thereof and multi-specific binding agents that bind an Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) peptide presented by HLA class I molecules, in particular, HLA-A02. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by expression of an EBV-LMP2 peptide presented by HLA-A02, in particular, Burkit's lymphoma, Hodgkin's lymphoma and nasopharyngeal carcinoma.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: December 10, 2019
    Assignees: MEMORIAL SLOAN KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Cheng Liu, Su Yan, Jingyi Xiang, Hong Liu
  • Publication number: 20190359732
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Application
    Filed: January 27, 2017
    Publication date: November 28, 2019
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Nai-Kong V. CHEUNG, Andres LOPEZ-ALBAITERO, Hong XU
  • Publication number: 20190353333
    Abstract: A set including a plug connectable LED and a packaged photocurable composition. It relates also to methods for applying that article. The photocurable composition includes cyanoacrylate monomers and/or acrylate monomers, and a visible light photoinitiator system. The plug connectable LED, when connected to a host mobile device including a rechargeable battery, allows energisation of the LED so that it can be used as a convenient light source to cure the photocurable composition. The set itself does not comprise a battery or, batteries. The set is a versatile consumer product in the field of adhesives, fillers, sealants and coatings.
    Type: Application
    Filed: January 25, 2017
    Publication date: November 21, 2019
    Applicant: AFINITICA TECHNOLOGIES, S. L.
    Inventors: Carles ORIOL MARGARIT, Ciaran MCARDLE, Juan Andrés LÓPEZ MAESO
  • Publication number: 20190118446
    Abstract: An apparatus for controlling the rate of flow of mold material to a mold cavity, the apparatus comprising: an injection molding machine and a manifold; an actuator interconnected to a valve pin having a tip end; a valve system in fluid communication with the actuator to drive the actuator at one or more rates of travel, the valve system having a start position, one or more intermediate drive rate positions and a high drive rate position, the start position holding the valve pin in a gate closed position; a controller that instructs the valve system to move from the start position to the one or more intermediate drive rate positions and to remain in the one or more intermediate drive rate positions for one or more corresponding predetermined amounts of time.
    Type: Application
    Filed: December 17, 2018
    Publication date: April 25, 2019
    Inventors: Vito Galati, Sergio Ribeiro de Oliveira Antunes, J. Andres Lopez
  • Publication number: 20190068382
    Abstract: A plurality of authentication devices form and manage a self-organizing mobile peer-to-peer mesh network to provide robust authentication of mobile peers, humans and or mobile devices such as drones, cars, satellites, robots etc. The mesh network may supplement traditional fixed point of entry authentication to combat social engineering penetrations or be used in situations where fixed-point authentication is not viable. Network efficiency can be enhanced by using two-level encryption, a first level of encryption based on permissions to join a mesh network and a simpler second level of encryption based on knowledge shared with members of the network for communication. Making the permissions a function of location can make the network more robust. Re-authenticating member peers based on the occurrence of defined events can further enhance security.
    Type: Application
    Filed: August 17, 2018
    Publication date: February 28, 2019
    Inventors: David James Theodore, Blake Cameron Sims, Andres Rios, Hyperia Doe, Jesse Jonathan Lee, Alfonso Andres Lopez
  • Patent number: 10160150
    Abstract: An apparatus for controlling the rate of flow of mold material to a mold cavity, the apparatus comprising: an injection molding machine and a manifold; an actuator interconnected to a valve pin having a tip end; a valve system in fluid communication with the actuator to drive the actuator at one or more rates of travel, the valve system having a start position, one or more intermediate drive rate positions and a high drive rate position, the start position holding the valve pin in a gate closed position; a controller that instructs the valve system to move from the start position to the one or more intermediate drive rate positions and to remain in the one or more intermediate drive rate positions for one or more corresponding predetermined amounts of time.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: December 25, 2018
    Assignee: SYNVENTIVE MOLDING SOLUTIONS, INC.
    Inventors: Vito Galati, Sergio Ribeiro de Oliveira Antunes, J. Andres Lopez
  • Patent number: 10144851
    Abstract: The present invention relates to a cyanoacrylate composition having a heterogeneous curing initiator which is a hydrated calcium silicate. The composition is suitable for repairing and filling depressions, cracks, or holes in a substrate or between substrates to be bonded. It also relates to an adhesive comprising said composition, to a syringe containing it, to a method for bonding substrates, to the use of said composition, and to the use of said hydrated calcium silicate as curing agent for cyanoacrylate compositions.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: December 4, 2018
    Assignee: AFINITICA TECHNOLOGIES, S. L.
    Inventors: Ciaran McArdle, Arnau Pejoan Jiménez, Juan Andrés López Maeso, Stefano Gherardi
  • Publication number: 20180273623
    Abstract: Provided herein are compositions, methods, and uses involving bispecific binding molecules that specifically bind to HER2, a receptor tyrosine kinase, and to CD3, a T cell receptor, and mediate T cell cytotoxicity for managing and treating disorders, such as cancer. Also provided herein are uses and methods for managing and treating HER2-related cancers.
    Type: Application
    Filed: January 26, 2018
    Publication date: September 27, 2018
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Nai-Kong V. Cheung, Andres Lopez-Albaitero, Hong Xu
  • Publication number: 20180258187
    Abstract: Described herein are antibodies, fragments thereof and multi-specific binding agents that bind an Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) peptide presented by HLA class I molecules, in particular, HLA-A02. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by expression of an EBV-LMP2 peptide presented by HLA-A02, in particular, Burkit's lymphoma, Hodgkin's lymphoma and nasopharyngeal carcinoma.
    Type: Application
    Filed: June 9, 2016
    Publication date: September 13, 2018
    Inventors: Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Cheng Liu, Su Yan, Jingyi Xiang, Hong Liu
  • Publication number: 20180215973
    Abstract: Fast light curing adhesive compositions, which include cyanoacrylate or methylidene malonate monomers or mixtures thereof, and either a photoinitiator system with a combination of specific ferrocene compounds and specific acylgermane compounds or a photoinitiator system with a specific ferrocene compound substituted with acylgermane groups. The use of that light curable adhesive composition, and a package.
    Type: Application
    Filed: February 25, 2016
    Publication date: August 2, 2018
    Applicant: AFINITICA TECHNOLOGIES, S.L.
    Inventors: Juan Andrés LÓPEZ MAESO, Ciaran MCARDLE, Cristina MONFORT FRAGA, Verónica DE LA FUENTE MOLINA, Arnau PEJOAN JIMÉNEZ, Vladimir TCHAPLINSKI